Rohto Pharmaceutical Co.,Ltd. provided dividend guidance of JPY 12.00 per share for the fiscal year ending March 31, 2024 as compared to paid dividend of JPY 12.00 per share a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,036 JPY | +2.50% | +4.03% | +6.79% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.79% | 4.4B | |
+25.83% | 661B | |
+27.42% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.96% | 231B | |
+5.26% | 200B | |
-9.24% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Rohto Pharmaceutical Co.,Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024